
CUSABIO develops life science reagents for protein research, biomarker detection and biological drug development. Its catalog covers ELISA kits, recombinant proteins, antibodies, stable cell lines, peptides and selected molecular biology products.
The brand is particularly strong in ELISA assays and recombinant proteins. It also offers specialized products for transmembrane targets, ADC development, CAR-T research and therapeutic antibody discovery.
CUSABIO provides ELISA kits for cytokines, hormones, enzymes, growth factors, receptors and disease-related biomarkers. The portfolio covers human samples as well as many laboratory and veterinary animal species.
Available assay categories include:
These products are used in immunology, oncology, neuroscience, metabolism, cardiovascular research and infectious disease studies.
Before selecting an ELISA kit, researchers should confirm the target species, compatible sample type, detection range and expected analyte concentration. Serum, plasma, cell culture supernatant and tissue homogenate may require different dilution or preparation procedures.
The CUSABIO protein portfolio includes recombinant proteins, active proteins, native proteins and transmembrane proteins. Common product groups include cytokines, growth factors, enzymes, receptors, viral antigens and immune checkpoint proteins.
Different expression systems are available, including:
Mammalian-expressed proteins are often preferred when native folding and post-translational modification are important. Bacterial expression may offer a practical option for proteins that do not require complex glycosylation.
Researchers should compare the sequence, expression system, tag, purity, endotoxin level and biological activity before ordering.
Transmembrane proteins are a distinctive part of the CUSABIO portfolio. These difficult-to-express targets include G protein-coupled receptors, chemokine receptors, ion channels and other cell-surface proteins.
CUSABIO uses several formats to maintain membrane-protein structure and solubility:
These proteins can support antibody discovery, ligand binding, immunization, structural research and drug screening. The correct format depends on whether the experiment requires an intact extracellular domain, native membrane environment or purified full-length protein.
CUSABIO offers recombinant, monoclonal and polyclonal antibodies. Secondary antibodies, tag antibodies, loading-control antibodies and labeled antibodies are also available.
Applications vary by product and may include:
The catalog also includes antibodies for less common species, modified histones, small molecules and therapeutic drug research. Researchers should check the listed application validation rather than relying only on target and species information.
CUSABIO supplies reagents for antibody-drug conjugate research. These products cover multiple stages of ADC development, from target selection to pharmacokinetic and immunogenicity analysis.
Relevant products include:
Targets such as EGFR, DLL3, NECTIN4 and other tumor-associated surface proteins are relevant to ADC screening and functional evaluation.
For CAR-T development, CUSABIO provides target proteins, stable cell lines, antibodies, cytokines and custom services. These products can support scFv screening, CAR expression analysis, T-cell expansion and in vitro potency testing.
Anti-CAR linker antibodies help researchers detect commonly used CAR components. Flow cytometry antibodies can be used to characterize immune-cell populations, while cytokine ELISA kits support functional evaluation after target-cell stimulation.
Custom anti-idiotype antibody services may also assist with CAR-T detection, pharmacokinetic analysis and immunogenicity studies.
CUSABIO offers stable cell lines expressing selected receptors, antigens and signaling targets. These models can be used for antibody screening, cell binding, internalization studies and functional validation.
A stable cell line can reduce the time required to construct and screen an internal model. However, researchers should confirm the host cell, expression level, selection marker, culture medium and intended assay before purchase.
The product range includes ELISA kits and small-molecule antigens for food safety and residue analysis. These products may be used to investigate antibiotics, toxins, hormones and other low-molecular-weight compounds.
Competitive ELISA is commonly used for small molecules because many of these targets cannot support a conventional two-antibody sandwich assay.
The intended sample matrix and extraction procedure are especially important in food testing. A research assay should not be presented as a regulatory or clinical diagnostic test unless the individual product carries the required certification.
CUSABIO products support research in:
The catalog also covers major signaling pathways such as PI3K-AKT, MAPK, JAK-STAT, mTOR, Wnt, Notch, TGF-beta, Hippo, apoptosis and autophagy.
CUSABIO provides custom protein expression, antibody development, peptide synthesis, gene synthesis and oligonucleotide synthesis.
Available antibody discovery and development services include hybridoma screening, single B-cell discovery, VHH library screening, phage display and recombinant antibody production. The company also offers SPR binding analysis and stable cell-line development.
For custom projects, the required sequence, expression system, purification method, scale, quality specification and downstream application should be defined before quotation.
For ELISA kits, begin with the target species and sample matrix. Review the assay range and sensitivity to ensure that expected concentrations can be measured without excessive dilution.
For recombinant proteins, pay close attention to the expression system and product format. A soluble extracellular domain may work for an ELISA standard but may not reproduce the behavior of a full-length transmembrane protein.
For antibodies, confirm species reactivity, validated application, expected molecular weight and available experimental images. Most CUSABIO catalog products are supplied for research use only and are not intended for clinical diagnosis or therapeutic use unless specifically stated.
Official website link: